SARS-CoV-2 Multi-Antigen Serology Module for Automated Western Blotting Systems
The SARS-CoV-2 Multi-Antigen Serology Module (SA-001) for use with Jess™ and Wes™ automated western blotting systems enables the detection of human IgG antibodies in human serum or plasma reactive against multiple SARS-CoV-2 antigens. With this antigen down serology assay, you can quantitatively characterize serum or plasma human IgG antibodies reactive against recombinant Nucleocapsid Protein (N), S1 receptor binding domain protein (RBD), S1 subunit full length, S2 subunit full length, and Spike (S1+S2) viral antigens within one 3-hour run! Learn more about the benefits of the SARS-CoV-2 serology assay that include the ability to:
- Quantify differences in patient serum antibody binding patterns using 5 different SARS-CoV-2 antigens in each sample
- Speed up your COVID-19 studies with minimal set-up time, hands-free operation and fully analyzed results on 24 samples in 3 hours.
- Access your results remotely to minimize time in the lab
Additional Resources
“Bio-Techne is Helping Scientists Discover Answers about SARS-CoV-2 and COVID-19”
Discover product answers about SARs COV-2 and COVID-19.
“SimplePlex for COVID-19 Research”
Profile the inflammatory response during COVID-19 with SimplePlex automated immunoassays.
“COVID-SeroIndex”
This quantitative ELISA test targets the SARS-CoV-2 spike protein, which has been shown in recent studies to correlate with neutralization activity.